Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: Febuxostat Versus Allopurinol Control Trial in Subjects With Gout [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing febuxostat to allopurinol in gout patients, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)
  • Uloric (febuxostat)

Snippet

Sponsor: Takeda | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2009-07-16